Pathstone Holdings, LLC Kronos Bio, Inc. Transaction History
Pathstone Holdings, LLC
- $21.2 Billion
- Q1 2024
A detailed history of Pathstone Holdings, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 11,984 shares of KRON stock, worth $14,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,984
Previous 12,034
0.42%
Holding current value
$14,860
Previous $15,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KRON
# of Institutions
60Shares Held
21.7MCall Options Held
4.8KPut Options Held
0-
Bvf Inc San Francisco, CA2.91MShares$3.6 Million0.11% of portfolio
-
Vida Ventures Advisors, LLC2.77MShares$3.43 Million5.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.42 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.27 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.78 Million0.08% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $70.4M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...